Dative Pharma Private Limited
About Dative Pharma Private Limited
Data last updated:
Dative Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the medical consumables and supplies segment of the healthcare sector. It was incorporated on 29 June 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24232PN2015PTC155589. Its GSTIN is 27AAFCD3803Q1ZC (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rajkumar Parappa Arali and Prakash Dnyaneshwar Kharabi.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Gat No 251 Kharabwadi Chakan Pune, Maharashtra, India – 410501.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Dative Pharma Private Limited's registered office is in Pune, Maharashtra.
- Registered AddressGat No 251 Kharabwadi Chakan Pune, Maharashtra, India – 410501
- IndustryHealthcare, Medical Consumables & Supplies
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Dative Pharma Private Limited
FY 2019 filings availableFinancial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ||||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ||||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Dative Pharma Private Limited, buy the company report.
Board of directors of Dative Pharma Private Limited
Dative Pharma has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajkumar Parappa Arali | Director | 29 Jun 2015 | 11 Years 3 Months | Current |
| Prakash Dnyaneshwar Kharabi | Director | 29 Jun 2015 | 11 Years 3 Months | Current |
| Padmakar Limbrao Gore | Director | 29 Jun 2015 | 11 Years 3 Months | Current |
| Vishwas Maruti Kadam | Director | 29 Jun 2015 | 11 Years 3 Months | Current |
Legal cases
No court or tribunal cases involving Dative Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dative Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dative Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCD3803Q1ZC | Maharashtra | Active | 24 Aug 2017 |
To see the full GST registrations and return filing status of Dative Pharma Private Limited, buy the company report.
Recent activity
Dative Pharma Private Limited has 4 board changes on record since 2015: 4 appointments. The latest: Padmakar Limbrao Gore was appointed as Director on 29 Jun 2015.
Frequently asked questions
Dative Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in medical consumables and supplies, within the healthcare industry. It was incorporated on 29 June 2015 (11+ years old) and is registered under CIN U24232PN2015PTC155589.
Dative Pharma has 4 current directors:
- Rajkumar Parappa Arali - Director
- Prakash Dnyaneshwar Kharabi - Director
- Padmakar Limbrao Gore - Director
- Vishwas Maruti Kadam - Director
The latest financial statements of Dative Pharma on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Dative Pharma is 27AAFCD3803Q1ZC, registered in Maharashtra.
The CIN (Corporate Identification Number) of Dative Pharma is U24232PN2015PTC155589. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dative Pharma was incorporated on 29 June 2015, making it 11+ years old. It is registered with the Registrar of Companies, Pune.
Padmakar Limbrao Gore was appointed as Director on 29 Jun 2015. Prakash Dnyaneshwar Kharabi was appointed as Director on 29 Jun 2015. Rajkumar Parappa Arali was appointed as Director on 29 Jun 2015. Dative Pharma has 4 board changes on record in total.
The registered office of Dative Pharma is at Gat No 251 Kharabwadi Chakan Pune, Maharashtra, India – 410501.
Dative Pharma operates in the healthcare industry, in the medical consumables and supplies segment.
The compliance status of Dative Pharma is compliant as of 04 September 2026. The company is actively filing with the Registrar of Companies.